ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 132 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $8,182,000 | -69.4% | 377,728 | -60.2% | 0.05% | -66.9% |
| Q2 2022 | $26,699,000 | +56.7% | 950,151 | +157.3% | 0.16% | +103.9% |
| Q1 2022 | $17,041,000 | -45.1% | 369,329 | 0.0% | 0.08% | -33.6% |
| Q4 2021 | $31,046,000 | -10.0% | 369,329 | -28.7% | 0.12% | -17.7% |
| Q3 2021 | $34,500,000 | +34.4% | 517,712 | +7.3% | 0.14% | +27.0% |
| Q2 2021 | $25,672,000 | +31.5% | 482,558 | +7.2% | 0.11% | -8.3% |
| Q1 2021 | $19,526,000 | +67.1% | 450,000 | +100.0% | 0.12% | +70.4% |
| Q4 2020 | $11,687,000 | – | 225,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 300,434 | $25,254,000 | 7.21% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,628,409 | $220,944,000 | 6.56% |
| Avidity Partners Management LP | 2,715,000 | $228,223,000 | 4.84% |
| Matrix Capital Management Company, LP | 4,349,279 | $365,600,000 | 4.07% |
| Affinity Asset Advisors, LLC | 117,500 | $9,877,000 | 3.59% |
| Integral Health Asset Management, LLC | 120,000 | $10,087,000 | 2.79% |
| Ghost Tree Capital, LLC | 80,000 | $6,725,000 | 2.41% |
| Ikarian Capital, LLC | 191,140 | $16,067,000 | 2.39% |
| Tri Locum Partners LP | 23,632 | $1,987,000 | 0.78% |
| Eventide Asset Management | 529,000 | $44,468,000 | 0.57% |